Report: U.S. spinal market to reach $6.6B by 2021

A trend toward more minimally invasive surgeries will lead to modest growth in the U.S. spinal implant market over the next several years, and the sector will hit the $6.6 billion mark by 2021, Millennium Research Group said. Reimbursement challenges and the medical device tax will hamper broader growth, Millennium noted, but the sector will still expand, in part, as surgeons switch to minimally invasive surgeries for treatments. While the spinal fusion implant market is very mature, the nonfusion implant market is growing quickly, Millennium said, adding that NuVasive, Globus Medical and LDR Spine have all launched new cervical artificial discs in recent months. Item

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.